This Week in Nature

In Nature this week, Broad Institute scientists describe an improved version of the genome-editing technology CRISPR/Cas9. Though widely used, the reliance of the approach on the relatively large Cas9 enzyme, which cuts DNA in specific locations, has restricted its use to cell lines and embryonic manipulation. The researchers were able to alter the system to use a smaller version of the Cas9 enzyme that was discovered in the bacteria Staphylococcus aureus.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.